NCT06805305
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06805305
Title DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Diakonos Oncology Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.